Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets
Condition(s):Liver Cancer; Pancreatic CancerLast Updated:March 3, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Liver Cancer; Pancreatic CancerLast Updated:March 3, 2017Completed
Condition(s):Surgery–Complications; Patient Satisfaction; Quality of LifeLast Updated:February 29, 2024Completed
Condition(s):Cystic FibrosisLast Updated:November 21, 2018Completed
Condition(s):Multiple Sclerosis; SpasticityLast Updated:April 25, 2022Completed
Condition(s):Sarcoma,Soft TissueLast Updated:February 16, 2024Not yet recruiting
Condition(s):Metastatic Breast Cancer; Metastatic Lung Cancer; Metastatic Prostate Cancer; Bone MetastasesLast Updated:December 18, 2023Recruiting
Condition(s):GlaucomaLast Updated:September 5, 2011Completed
Condition(s):Osteoarthritis; Cardiovascular DiseaseLast Updated:July 27, 2020Terminated
Condition(s):HypertensionLast Updated:August 5, 2014Completed
Condition(s):Osteoarthritis; GonarthrosisLast Updated:January 13, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.